₹ 0.0 Cr
Volume transacted
0.1 K
stocks traded
Last Updated time: 26 Jul 09:33 AM
Aarey Drugs & Pharmaceuticals Ltd
NSE: AAREYDRUGS
PE
27.2
Last updated : 26 Jul 09:33 AM
The P/E Ratio of Aarey Drugs & Pharmaceuticals Ltd is 27.2 as of 26 Jul 09:33 AM .a1#The P/E Ratio of Aarey Drugs & Pharmaceuticals Ltd changed from 10.3 on March 2019 to 15.9 on March 2023 . This represents a CAGR of 9.07% over 5 years. a1#The Latest Trading Price of Aarey Drugs & Pharmaceuticals Ltd is ₹ 51.37 as of 26 Jul 09:26 .a1#The PE Ratio of Pharmaceuticals Industry has changed from 28.3 to 27.2 in 5 years. This represents a CAGR of -0.79%a1# The PE Ratio of Automobile industry is 18.9. The PE Ratio of Finance industry is 23.0. The PE Ratio of IT - Software industry is 29.1. The PE Ratio of Pharmaceuticals industry is 38.6. The PE Ratio of Retail industry is 143.1. The PE Ratio of Textiles industry is 24.3. In 2024a1#The Market Cap of Aarey Drugs & Pharmaceuticals Ltd changed from ₹ 67.58 crore on March 2019 to ₹ 60.09 crore on March 2023 . This represents a CAGR of -2.32% over 5 years. a1#The Revenue of Aarey Drugs & Pharmaceuticals Ltd changed from ₹ 119.7 crore to ₹ 215.49 crore over 8 quarters. This represents a CAGR of 34.17% a1#The EBITDA of Aarey Drugs & Pharmaceuticals Ltd changed from ₹ 1.75 crore to ₹ 3.7 crore over 8 quarters. This represents a CAGR of 45.41% a1#The Net Pr of Aarey Drugs & Pharmaceuticals Ltd changed from ₹ 0.8 crore to ₹ 2.15 crore over 8 quarters. This represents a CAGR of 63.94% a1#The Dividend Payout of Aarey Drugs & Pharmaceuticals Ltd changed from 3.57 % on March 2019 to 0 % on March 2023 . This represents a CAGR of -100.00% over 5 years. a1#
Open Demat Account
Enter your mobile no. to continue
+91
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Period | |
---|---|
Mar '19 | 10.3 |
Mar '20 | 5.4 |
Mar '21 | 8.3 |
Mar '22 | 16 |
Mar '23 | 15.9 |
Market Cap
₹ 127 Cr
EPS
₹ 1.9
P/E Ratio (TTM) *
27.2
P/B Ratio (TTM) *
1.0
Day’s High
₹ 51.37
Day’s Low
₹ 50.25
DTE *
0.2
ROE *
3.5
52 Week High
₹ 68.0
52 Week Low
₹ 31.5
ROCE *
4.3
* All values are consolidated
Last Updated time: 26 Jul 09:33 AM
* All values are consolidated
Last Updated time: 26 Jul 09:33 AM
Aarey Drugs & Pharmaceuticals Ltd
NSE: AAREYDRUGS
PRICE
₹ 51.37
1.12 (2.23%)
Last updated : 26 Jul 09:26
The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.
1M
1Y
3Y
5Y
* All values are in Rupees
Strength
0
S
Weakness
0
W
Opportunity
0
O
Threats
1
T
Market Value
₹ 128
-0.5 X
Value addition
Asset Value
₹ 271
* All values are in Rupees
Company Name | PE | Market Cap (INR Cr.) |
---|---|---|
Aarey Drugs & Pharmaceuticals Ltd | 27 | 127 |
Sun Pharmaceuticals Industries Ltd | 40 | 399,537 |
Zydus Lifesciences Ltd | 31 | 121,312 |
Cipla Ltd | 28 | 121,120 |
Divis Laboratories Ltd | 75 | 120,782 |
Dr Reddys Laboratories Ltd | 20 | 114,348 |
Earnings
₹6 Cr
27.2 X
PE Ratio
Market Cap
₹127.56Cr
PE Ratio
PS Ratio
PB Ratio
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.
P/E ratio = (CMP of share/ Earning per share)
1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Earnings
₹6 Cr
27.2 X
PE Ratio
Market Cap
₹127.56Cr
PE Ratio
PS Ratio
PB Ratio
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.
P/E ratio = (CMP of share/ Earning per share)
1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
Period | |
---|---|
Mar '19 | 68 |
Mar '20 | 31 |
Mar '21 | 54 |
Mar '22 | 105 |
Mar '23 | 60 |
* All values are a in ₹crore
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.
Period | |
---|---|
Jun '22 | 120 |
Sep '22 | 75 |
Dec '22 | 63 |
Mar '23 | 164 |
Jun '23 | 52 |
Sep '23 | 59 |
Dec '23 | 77 |
Mar '24 | 215 |
* All values are a in ₹crore
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Period | |
---|---|
Jun '22 | 2 |
Sep '22 | 3 |
Dec '22 | 2 |
Mar '23 | 3 |
Jun '23 | 2 |
Sep '23 | 3 |
Dec '23 | 3 |
Mar '24 | 4 |
* All values are a in ₹crore
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue
Period | |
---|---|
Jun '22 | 1 |
Sep '22 | 2 |
Dec '22 | 1 |
Mar '23 | 0 |
Jun '23 | 1 |
Sep '23 | 1 |
Dec '23 | 2 |
Mar '24 | 2 |
* All values are a in ₹crore
Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.
Period | |
---|---|
Mar '19 | 4 |
Mar '20 | 0 |
Mar '21 | 0 |
Mar '22 | 0 |
Mar '23 | 0 |
* All values are a in %
Aarey Drugs & Pharmaceuticals Ltd was originally incorporated on May 15, 1990 as a private limited company in Mumbai with the name Niharika Textiles & Chemicals Pvt Ltd. The company was originally promoted by Prakash Mandhana, Kavita Mandhana and Neeta Mandhana. In March, 1993, the Aarey Group of companies belonging to Ghatalia family took over the company and the company was converted into public limited company. Also, the name of the company was changed from Niharika Textiles & Chemicals Pvt Ltd to Aarey Drugs & Pharmaceuticals Ltd. The Company is one of the manufacturer and suppliers of pharmaceutical raw materials, Chemicals, Pharmaceuticals ingredients, API's Drugs, Food Colours and Flavours. The company is engaged in the business of manufacturing, selling of drugs & pharmaceutical products and is governed by a number of central and state legislations that regulate the business. Apart from the bulk drug manufacturing activity, they also undertake importing & distributing of various industrial chemicals & solvents throughout the country. The company has their manufacturing unit located at Thane. The company's products include Methyl Nitro Imidazole, Metronidazole & Metronidazole Benzoate. Their pharmaceutical products are sourced from the authentic vendors to assure the quality and effectiveness. The pharmaceutical products offered by the company are in compliance with IP/ BP/ CP/ USP standards. They have their registered office is located at Thane and their corporate office is located at Mumbai. The company was established with the main object setting up manufacturing facilities for Bulk Drugs. In the year 1993, the company came with a public issue of 27,50,000 equity shares of Rs 10 each for cash at par aggregating to Rs 275 lakh. Also, the company shares were listed on the BSE, ASE & DSE. In May 2009, the company plant started to upgrade the existing plant into international standards. In June 2016, the Company commenced manufacturing of Mono Methyl Urea & Di Methyl Urea. In 2017-18, it added new products i.e. Erithromycin Derivates & Mafenamic Acid with capacity of 10 m.t. & 25 m.t. respectively in June' 2017. In 2018-19, it commenced manufacturing of products i.e. Ortho Para Nitro Anisole, 2-Bromomethyl-1,3 dioxolane, and Mefenamic Acid. It also commenced manufacturing products i.e.Metformin & Urasil.
Aarey Drugs & Pharmaceuticals to hold board meeting
Aarey Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company...
Read more
28 May 202415:38
Aarey Drugs & Pharmaceuticals to consider Preferential Issue
Aarey Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company...
Read more
20 Mar 202417:09
Aarey Drugs & Pharmaceuticals schedules board meeting
Aarey Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company...
Read more
08 Feb 202410:22
Aarey Drugs & Pharmaceuticals to conduct EGM
Aarey Drugs & Pharmaceuticals announced that an Extra Ordinary General Meeting (EGM) of th...
Read more
07 Dec 202312:09
Aarey Drugs & Pharmaceuticals to conduct board meeting
Aarey Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company...
Read more
09 Nov 202311:04
Aarey Drugs & Pharmaceuticals to conduct board meeting
Aarey Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company...
Read more
08 Aug 202317:05
FAQs for PE of Aarey Drugs & Pharmaceuticals Ltd
What is Aarey Drugs & Pharmaceuticals Ltd current share price?
What is Aarey Drugs & Pharmaceuticals Ltd's market cap?
What are Aarey Drugs & Pharmaceuticals Ltd's total net assets?
Is Aarey Drugs & Pharmaceuticals Ltd making a profit or loss?
Unlimited trading at just
Rs. 199